<DOC>
	<DOCNO>NCT02861092</DOCNO>
	<brief_summary>It exist recommendation get optimal antibiotic treatment bone joint infection prescription antibiotic bone joint infection material meet certain obligation : micro-organism must know , antibiotic therapy must start association , obtain high plasma level , use molecule good bone circulation . It recommend initially administer treatment intravenous route propose oral relay , condition . It recommend administer antibiotic treatment least 6 week . The dosage antibiotic adapt weight patient order respond recommendation . But little known optimal dose treatment give obese patient ( BMI &gt; =30 ) frequency serious adverse event patient dosage high important compare non-obese patient . The aim study evaluate risk occurrence serious adverse event obese patient identify risk factor . This study consist retrospective cohort obese patient treat bone joint infection serious adverse event . Several data collect concerning : demographic data , treatment responsible serious adverse event ( molecule , dosage , route ) , description serious adverse event , residual rate vancomycin .</brief_summary>
	<brief_title>Antibiotic-related Serious Adverse Events Obese Patients Treated Bone Joint Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>patient ( i.e age â‰¥ 15 yearold ) bone joint infection without implant BMI &gt; =30 serious adverse event relate antibiotic treatment .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Serious adverse event</keyword>
	<keyword>bone joint infection</keyword>
	<keyword>obesity</keyword>
	<keyword>dose adjustment</keyword>
</DOC>